Effectiveness of Multimodal Intervention on Health-Related Quality of Life And Treatment Adherence among Hypertensive Patients in Selected Community Of Jumla, Nepal
DOI:
https://doi.org/10.70280/njph(2026)v3i1.68Abstract
Background: Hypertension continues to be a global health issue, with rates of prevalence rising quickly in both developed and developing nations. Adherence to or compliance with hypertensive medications has significant economic and therapeutic consequences because nonadherence patients are at greater risk of developing complications affecting their health status and overall quality of life. The research aimed to determine the effects of multimodal intervention on health related quality of life and treatment adherence in hypertensive patients
Methods: A quasi-experimental one-group pretest–posttest design was used among 218 hypertensive patients in Chandannath Municipality, Jumla. Participants aged ≥18 years, diagnosed with hypertension for at least 6 months, and on antihypertensive medication were included using non-probability consecutive sampling. Data were collected using WHOQOL-BREF and Hill-Bone Compliance Scale. A multimodal intervention package (education, counseling, leaflet, and telephonic follow-up) was implemented. Data were analyzed using SPSS version 21. Descriptive statistics and paired t-test were used.
Results: The study revealed that 17.9% of respondents had perfect adherence during pretest which was significantly increased to 40.8% during posttest. Similarly, 16.1% of respondents had high health related quality of life during pre test which was significantly increased to 23.9% during posttest.
Conclusions: It was concluded that the adherence and quality of life both were improved after the implementation of multimodal interventions. Therefore, the combination of educational interventions, attentive listening, and dialogue established within health facilities and community spaces can help patients make decisions about using strategies or actions to improve their treatment adherence and quality of life.
References
1. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015 386:801–12.
2. World Health Organization. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization; 2013.
3. World Health Organization. The world health report 2002: reducing risks, promoting healthy life. World Health Organization; 2002.
4. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR, Andrews KG, Aryee M. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012 Dec 15;380(9859):2224-60.
5. World Health Organization. Global health observatory data repository. WHO, Geneva, Switzerland, 2015
6. Annual Report, Department of Health Sciences, Government of Nepal, 2075/76
7. Ministry of Health Nepal, New ERA, ICF. 2016 Nepal Demographic and Health Survey. Kathmandu, Nepal. 2017.
8. Nepal Health Research Council. Nepal STEPS Survey 2019 - Fact Sheets Kathmandu, Nepal: Nepal Health Research Council. 2019
9. Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. New England Journal of Medicine. 2010.
10. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European journal of health economics. 2010 Apr 1;11(2):215-25.
11. Yang Q, Chang A, Ritchey MD, Loustalot F. First-year vs Long-term Assessment of Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults. Circulation. 2017 Nov 14;136(suppl_1):A14886-.
12. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M. A new taxonomy for describing and defining adherence to medications. British journal of clinical pharmacology. 2012 May;73(5):691-705.
13. Gottlieb H. Medication nonadherence: finding solutions to a costly medical problem CME. Drug benefit trends. 2000;12(6):57-62.
14. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of internal medicine. 2006 Sep 25;166(17):1836-41.
15. Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes care. 2012 Jun 1;35(6):1279-84.
16. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Medical care. 2005 Jun 1:521-30
17. Neupane D, Kallestrup P. Non-communicable diseases in Nepal: challenges and opportunities. Journal of Nepal Health Research Council. 2013 May;11(24):225-8.
18. Vaidya A, Shakya S, Krettek A. Obesity prevalence in Nepal: public health challenges in a low-income nation during an alarming worldwide trend. International journal of environmental research and public health. 2010 Jun;7(6):2726-44.
19. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of internal medicine. 2006 Sep 25;166(17):1836-41.
20. World Health Organization. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version, December 1996. World Health Organization; 1996.
21. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill‐bone compliance to high blood pressure therapy scale. Progress in cardiovascular nursing. 2000 Jun;15(3):90-6
22. Bani-Issa W. Evaluation of the health-related quality of life of Emirati people with diabetes: integration of sociodemographic and disease-related variables. East Mediterr Health J. 2011 Nov 1;17(11):825-30.
23. Shakya R, Shrestha S, Gautam R, Rai L, Maharjan S, Satyal GK, Kc B, Rai MK. Perceived Illness and Treatment Adherence to Hypertension Among Patients Attending a Tertiary Hospital in Kathmandu, Nepal. Patient preference and adherence. 2020;14:22
24. Sheilini M, Hande HM, Prabhu MM, Pai MS, George A. Impact of multimodal interventions on medication nonadherence among elderly hypertensives: a randomized controlled study. Patient preference and adherence. 2019;13:549.
25. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Annals of internal medicine. 2006 Apr 4;144(7):475-84.
26. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman medical journal. 2011 May;26(3):155.
27. Adisa R, Alutundu MB, Fakeye TO. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice. 2009 Jul;7(3):163
28. Abdi NS. Improving Adherence to Antihypertensive Medications Among Somali Patients in a Primary Care Clinic.
29. de Souza AC, Moreira TM, Oliveira ES, Menezes AV, Loureiro AM, Silva CB, Linard JG, Almeida IL, Mattos SM, Borges JW. Effectiveness of educational technology in promoting quality of life and treatment adherence in hypertensive people. PLoS One. 2016 Nov 16;11(11):e0165311.
30. Sa'ed HZ, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R, Morisky DE. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. International Journal of Cardiology. 2013 Oct 3;168(3):2981-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 ANIKA DAHAL, Kamal Prasad Acharya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Nepal Journal of Public Health (NJPH) are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License. This license allows others to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
Under the following terms:
- Attribution: Appropriate credit must be given, a link to the license must be provided, and any changes made must be indicated. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
For more details about the license, please visit the Creative Commons website.
